Nicholas D. James, MBBS, PhD, on Prostate Cancer: Results From the STAMPEDE Trial

2017 ASCO Annual Meeting
Tweet this page

Nicholas D. James, MBBS, PhD, of Queen Elizabeth Hospital, discusses study findings on adding abiraterone for men with high-risk prostate cancer starting long-term androgen-deprivation therapy (Abstract LBA5003).

Advertisement

Advertisement



Advertisement